Methylglyoxal, a reactive glucose metabolite, increases renin angiotensin aldosterone and blood pressure in male sprague-dawley rats

American Journal of Hypertension

Volumn 27, Issue 3, 2014, Pages 308-316

  Dhar, Indu ^a   Dhar, Arti ^a   Wu, Lingyun ^b   Desai, Kaushik M ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b LAKEHEAD UNIVERSITY   (Canada)

Author keywords

blood pressure; diabetes; hyperglycemia; hypertension; methylglyoxal; receptor for advanced glycation end products; renin angiotensin aldosterone system

Indexed keywords

BLOOD PRESSURE; DIABETES; HYPERGLYCEMIA; HYPERTENSION; METHYLGLYOXAL; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS; RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM.;

ALDOSTERONE; ANGIOTENSINS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CATECHOLAMINES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HYPERTENSION; MALE; NF-KAPPA B; PYRUVALDEHYDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; RENIN; RENIN-ANGIOTENSIN SYSTEM; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; THIAZOLES; TIME FACTORS; UP-REGULATION;

EID: 84894230246     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt281     Document Type: Article

References (40)

1. Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet 2012; 380:601-610.
2. Crowley SD, Coffman TM. Recent advances involving the renin-angiotensin system. Exp Cell Res 2012; 318:1049-1056.
3. Hsueh WA, Wyne K. Renin-angiotensin-aldosterone system in diabetes and hypertension. J Clin Hypertens (Greenwich) 2011; 13:224-237.
4. Goossens GH. The renin-angiotensin system in the pathophysiology of type 2 diabetes. Obes Facts 2012; 5:611-624.
5. Dhar A, Desai K, Kazachmov M, Yu P, Wu L. Methylglyoxal production in vascular smooth muscle cells from different metabolic precursors. Metab Clin Exp 2008; 57:1211-1220.
6. Cooper RA. Metabolism of methylglyoxal in microorganisms. Annu Rev Microbiol 1984; 38:49-68.
7. Vander Jagt DL, Hunsaker LA. Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chemico-Biol Interact 2003; 143-144:341-351.
8. Wang H, Meng QH, Gordon JR, Khandwala H, Wu L. Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus. Clin Biochem 2007; 40:1232-1239.
9. McLellan AC, Thornalley PJ, Benn J, Sonksen PH. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci (London, England) 1994; 87:21-29.
10. Dhar A, Dhar I, Jiang B, Desai KM, Wu L. Chronic methylglyoxal infusion by minipump causes pancreatic beta-cell dysfunction and induces type 2 diabetes in Sprague-Dawley rats. Diabetes 2011; 60:899-908.
11. Desai KM, Wu L. Free radical generation by methylglyoxal in tissues. Drug Metabol Drug Interact 2008; 23:151-173.
12. Wu L, Juurlink BH. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 2002; 39:809-814.
13. Ceriello A. Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 2008; 31:S181-S184.
14. Wang X, Desai K, Chang T, Wu L. Vascular methylglyoxal metabolism and the development of hypertension. J Hypertens 2005; 23:1565-1573.
15. Wang X, Jia X, Chang T, Desai K, Wu L. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats. J Hypertens 2008; 26:765-772.
16. Dhar A, Desai KM, Wu L. Alagebrium attenuates acute methylglyoxalinduced glucose intolerance in Sprague-Dawley rats. Br J Pharmacol 2010; 159:166-175.
17. Desai KM, Gopalakrishnan V, Hiebert LM, McNeill JR, Wilson TW. EDHF-mediated rapid restoration of hypotensive response to acetylcholine after chronic, but not acute, nitric oxide synthase inhibition in rats. Eur J Pharmacol 2006; 546:120-126.
18. Heynekamp JJ, Weber WM, Hunsaker LA, Gonzales AM, Orlando RA, Deck LM, Jagt DL. Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB. J Med Chem 2006; 49:7182-7189.
19. Dhar A, Desai K, Liu J, Wu L. Methylglyoxal, protein binding and biological samples: are we getting the true measure? J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877:1093-1100.
20. BioSpace. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074. http://www.biospace.com/News/synvista-therapeutics- announces-termination-of/124306, 2009.
21. Gee ME, Janssen I, Pickett W, McAlister FA, Bancej CM, Joffres M, Johansen H, Campbell NR. Prevalence, awareness, treatment, and control of hypertension among Canadian adults with diabetes 2007 to 2009. Can J Cardiol 2012; 28:367-374.
22. Kaufman LN, Peterson MM, Smith SM. Hypertension and sympathetic hyperactivity induced in rats by high-fat or glucose diets. Am J Physiol 1991; 260:E95-E100.
23. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987; 10:512-516.
24. Madero M, Perez-Pozo SE, Jalal D, Johnson RJ, Sanchez-Lozada LG. Dietary fructose and hypertension. Curr Hypertens Rep 2011; 13:29-35.
25. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414:813-820.
26. Perez-Pozo SE, Schold J, Nakagawa T, Sanchez-Lozada LG, Johnson RJ, Lillo JL. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond) 2010; 34:454-461.
27. Vasdev S, Ford CA, Longerich L, Parai S, Gadag V, Wadhawan S. Aldehyde induced hypertension in rats: prevention by N-acetyl cysteine. Artery 1998; 23:10-36.
28. Vasdev S, Stuckless J. Role of methylglyoxal in essential hypertension. Int J Angiol 2010; 19:e58-e65.
29. Baskaran S, Balasubramanian KA. Effect of methylglyoxal on protein thiol and amino groups in isolated rat enterocytes and colonocytes and activity of various brush border enzymes. Ind J Biochem Biophys 1990; 27:13-17.
30. Wang X, Chang T, Jiang B, Desai K, Wu L. Attenuation of hypertension development by aminoguanidine in spontaneously hypertensive rats: role of methylglyoxal. Am J Hypertens 2007; 20:629-636.
31. Toma I, Kang JJ, Sipos A, Vargas S, Bansal E, Hanner F, Meer E, Peti-Peterdi J. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest 2008; 118:2526-2534.
32. Zhang SL, Filep JG, Hohman TC, Tang SS, Ingelfinger JR, Chan JS. Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kid Int 1999; 55:454-464.
33. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Int Med 2008; 264:224-236.
34. Zaman MA, Oparil S, Calhoun DA. Drugs targeting the renin-angiotensin- aldosterone system. Nat Rev Drug Dis 2002; 1:621-636.
35. Hitomi H, Kiyomoto H, Nishiyama A. Angiotensin II and oxidative stress. Curr Opin Cardiol 2007; 22:311-315.
36. Dhar A, Dhar I, Desai KM, Wu L. Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucose. Br J Pharmacol 2010; 161:1843-1856.
37. Lavrentyev EN, Estes AM, Malik KU. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells. Circ Res 2007; 101:455-464.
38. Wolffenbuttel BH, Boulanger CM, Crijns FR, Huijberts MS, Poitevin P, Swennen GN, Vasan S, Egan JJ, Ulrich P, Cerami A, Levy BI. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA 1998; 95:4630-4634.
39. Ramasamy R, Yan SF, Schmidt AM. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann N Y Acad Sci 2011; 1243:88-102.
40. Wendt T, Bucciarelli L, Qu W, Lu Y, Yan SF, Stern DM, Schmidt AM. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes. Curr Atheroscler Rep 2002; 4:228-237.